The pipeline of advanced therapy is expanding at a rate never seen before, with a number of cell and gene therapies now reaching the market. As a result, the services required to develop them are in more demand than ever. In this webinar we take a look at some of the promising therapies in development, and what is needed to ensure reliable, consistent and scalable manufacturing so that the price of these treatments can be reduced and they can become mainstream.
Arun Upadhyay, PhD
Vice President and Head of Research and Development
Sanjay Srivastava, PhD
Managing Director, Cell & Gene Therapy CoE Lead
Cell and Gene Therapy Catapult